AU5967899A - Inhibition of alopecia - Google Patents

Inhibition of alopecia

Info

Publication number
AU5967899A
AU5967899A AU59678/99A AU5967899A AU5967899A AU 5967899 A AU5967899 A AU 5967899A AU 59678/99 A AU59678/99 A AU 59678/99A AU 5967899 A AU5967899 A AU 5967899A AU 5967899 A AU5967899 A AU 5967899A
Authority
AU
Australia
Prior art keywords
alopecia
inhibition
relates
increased
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59678/99A
Inventor
Thomas Boehm
Natalia Meier
Thomas Schlake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of AU5967899A publication Critical patent/AU5967899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a method for inhibiting alopecia in which cellular quantities of hair keratins are increased. The invention also relates to a system for identifying substances which inhibit alopecia.
AU59678/99A 1998-07-13 1999-07-13 Inhibition of alopecia Abandoned AU5967899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19831043A DE19831043A1 (en) 1998-07-13 1998-07-13 Inhibition of alopecia
DE19831043 1998-07-13
PCT/DE1999/002185 WO2000002908A2 (en) 1998-07-13 1999-07-13 Inhibition of alopecia

Publications (1)

Publication Number Publication Date
AU5967899A true AU5967899A (en) 2000-02-01

Family

ID=7873682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59678/99A Abandoned AU5967899A (en) 1998-07-13 1999-07-13 Inhibition of alopecia

Country Status (7)

Country Link
EP (1) EP1097209B1 (en)
AT (1) ATE280828T1 (en)
AU (1) AU5967899A (en)
CA (1) CA2334168A1 (en)
DE (2) DE19831043A1 (en)
ES (1) ES2232189T3 (en)
WO (1) WO2000002908A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011269D0 (en) * 2000-05-11 2000-06-28 Univ Sheffield Protein over expression
EP1368493A2 (en) 2001-03-07 2003-12-10 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Identification and use of inhibitors of hair growth
KR101859421B1 (en) * 2017-01-31 2018-05-21 주식회사 케라메딕스 Injectable composition for prevention of depilation or improvement of hair growth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD58358A (en) *
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
WO1998046208A1 (en) * 1997-04-17 1998-10-22 The Regents Of The University Of Michigan Hair follicle dna delivery system
DE19736198C1 (en) * 1997-08-20 1998-12-24 Deutsches Krebsforsch Protease related protein

Also Published As

Publication number Publication date
DE59910945D1 (en) 2004-12-02
ATE280828T1 (en) 2004-11-15
ES2232189T3 (en) 2005-05-16
EP1097209B1 (en) 2004-10-27
WO2000002908A2 (en) 2000-01-20
WO2000002908A3 (en) 2000-06-22
EP1097209A2 (en) 2001-05-09
DE19831043A1 (en) 2000-01-27
CA2334168A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
DE59908887D1 (en) METHOD FOR AN OR DISCONNECTING CONSUMERS
AU1831597A (en) Methods and compositions for inhibiting hexokinase
EP0818448B8 (en) Cycloalkano-pyridine as CETP inhibitors
ZA987798B (en) Method for treating chapped lips
NO996358L (en) Systems for land-based vehicle distribution of listening natural gas
AP2000001919A0 (en) Inhibitors of caspases.
IL140686A0 (en) Compositions and methods for inhibiting fungal growth
WO1999004752A3 (en) Methods for treating skin pigmentation
IL135232A0 (en) 21-hydroxy-6, 19-oxidoprogesterone for treating excess of glucocorticoids
PL345590A1 (en) Method for phosphatizing, rerinsing and cathodic electro-dipcoating
WO1999055844A3 (en) Methods for modulating differentiation
AU2243797A (en) Methods and compositions for inhibiting hexokinase
BR9813778A (en) Use of at least one fucan.
AU4577999A (en) Methods and compositions for inhibiting corrosion
PL340807A1 (en) Method of and system for buffering files as well as configuration of said system
AU7604098A (en) Peptide compositions for tumor inhibition
DE69906856D1 (en) Method for inhibiting hair growth
AU5967899A (en) Inhibition of alopecia
DZ2292A1 (en) Method regarding cell immortality.
BG103649A (en) Method for the preparation of eprosartan
AU4297299A (en) Method for processing mineralised water
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
BG103650A (en) Method for the preparation of eprosartan
YU18399A (en) Process for alkylating hindered sulfonamides
AU1110799A (en) Method of inhibiting metastases of cancer cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase